HBW Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

ECHA Underscores Need For New Funding To Improve Functioning Of REACH, CLP

Executive Summary

In its third report on the operation of core chemicals safety management programs, the European Chemicals Agency highlights declining fee income in recent years and proposes a new financing model that would afford greater predictability and support for ongoing priorities.

You may also be interested in...



ECHA Says 15% Of Inspected Substances Have REACH Registration Problems

The results of the EU-wide REACH enforcement project are based on inspections of 813 companies in 2019, covering nearly 1,200 substances in total. The European Chemicals Agency previously committed to performing compliance checks on 30% of all REACH-registered substances by 2027.

EU Chemicals Strategy Stands To Transform Cosmetics Regulation

Cosmetics Europe Director-General John Chave says whichever way the European Commission proceeds under its recently released sustainable chemicals strategy, there almost certainly will need to be changes to the Cosmetic Products Regulation. Chave counts the strategy among “the biggest legislative policy proposals affecting our sector probably ever.”

REACH Phase-In Registration Is Over. Now What?

After 10 years and nearly 90,000 registrations, the phase-in period for existing chemicals under the EU’s REACH regulation is finished. New chemicals must continue to be registered, and substance dossiers have to kept up to date through ongoing cooperation between registrants, ECHA reminds industry.

Topics

UsernamePublicRestriction

Register

RS151412

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel